Tag Archives: Current Affairs

About 3D Printing

Govt readies 3D printing policy for local firms to join new global market In News The Ministry of Electronics and Information Technology (MeitY) will soon come up with a policy aimed at promoting 3D printing on an industrial scale. Objectives of the policy The policy will help to develop an ecosystem for design, development and deployment of 3D printing in the country. It

Read more

August Week-4, Q&A and CA

1) What is the economics behind e-vehicle batteries? https://upscexpress.com/2019/09/01/what-is-the-economics-behind-e-vehicle-batteries/ 2) Who are the 19 lakh excluded from Assam NRC, and what next for them? https://upscexpress.com/2019/09/01/who-are-the-19-lakh-excluded-from-assam-nrc-and-what-next-for-them/ 3)Science for disaster management Editorial 31st Aug’19 TimesOfIndia https://upscexpress.com/2019/09/01/science-for-disaster-management-editorial-31st-aug19-timesofindia/ 4)hat advantages does 3D printing have over traditional methods of manufacturing? What are its potential applications? https://upscexpress.com/2019/09/01/what-advantages-does-3d-printing-have-over-traditional-methods-of-manufacturing-what-are-its-potential-applications-15-marks/ 5)What are the major problems of agricultural marketing in

Read more

Why a dam in Karnataka bothers Tamil Nadu

Headline : Why a dam in Karnataka bothers Tamil Nadu Details : Why in news? Recently, Tamil Nadu Chief Minister E K Palaniswami wrote to the Prime Minister urging him to stop the process of a feasibility study for the Mekedatu dam project in Karnataka.   About Mekedatu dam project Being set up by the Karnataka government, the project is near Mekedatu,

Read more

NATIONAL PHARMACEUTICAL PRICING AUTHORITY:

NATIONAL PHARMACEUTICAL PRICING AUTHORITY: The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs and equipments in India. NPPA is an organization of the Government of India which was established to fix/ revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the

Read more